SHUKRAPHAR vs ARFIN: Stock Comparison
Head-to-head financial and trading comparison between Shukra Pharmaceuticals Limited (SHUKRAPHAR) and Arfin India Limited (ARFIN) in the Cross-Sector Peers sector.
SHUKRAPHAR
NSE: SHUKRAPHARARFIN
NSE: ARFINKey Metrics Comparison Table
| Metric | SHUKRAPHAR | ARFIN | Edge / Winner |
|---|---|---|---|
| Current Market Price (CMP) | ₹66.94 | ₹105.14 | — |
| 1-Year Price Return | +61.61% | +9.04% | SHUKRAPHAR (52.57% higher) |
| 52-Week High | ₹72.58 | ₹107.52 | — |
| 52-Week Low | ₹41.42 | ₹82.06 | — |
| 30-Day Annualized Volatility | 64.68% | 57.5% | ARFIN (Steadier) |
| 30-Day Average Daily Volume | 6,592,919 | 2,823,186 | SHUKRAPHAR (Higher Liquidity) |
| Statutory Cost to Trade ₹1 Lakh | ₹118.50 | ₹118.50 | Identical statutory tariff |
Frequently Asked Questions
Between SHUKRAPHAR and ARFIN, which stock gave better returns over the last year?
SHUKRAPHAR has outperformed ARFIN over the past 12 months with a gain of 61.61% compared to 9.04%.
Which stock is less volatile: SHUKRAPHAR or ARFIN?
ARFIN demonstrated lower price volatility (57.5% annualized) compared to SHUKRAPHAR (64.68%). Lower volatility generally indicates steadier price action during market downturns.
What is the statutory cost to buy ₹1,00,000 of SHUKRAPHAR vs ARFIN?
Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).
Are SHUKRAPHAR and ARFIN direct sector competitors?
Yes, both companies operate within the Cross-Sector Peers sector in India and are actively tracked as sector peers by institutional and retail market participants.